Omalizumab and the immune system: an overview of preclinical and clinical data.
about
The dilemma of occupational rhinitis: management options.Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease.Anti-IgE and Biologic Approaches for the Treatment of Asthma.Bicentre experience in the treatment of severe generalised atopic dermatitis with extracorporeal photochemotherapy.
P2860
Omalizumab and the immune system: an overview of preclinical and clinical data.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Omalizumab and the immune system: an overview of preclinical and clinical data.
@ast
Omalizumab and the immune system: an overview of preclinical and clinical data.
@en
type
label
Omalizumab and the immune system: an overview of preclinical and clinical data.
@ast
Omalizumab and the immune system: an overview of preclinical and clinical data.
@en
prefLabel
Omalizumab and the immune system: an overview of preclinical and clinical data.
@ast
Omalizumab and the immune system: an overview of preclinical and clinical data.
@en
P1476
Omalizumab and the immune system: an overview of preclinical and clinical data
@en
P2093
S G O Johansson
P304
P356
10.1016/S1081-1206(10)61928-X
P577
2002-08-01T00:00:00Z